References
- Hu SS. Blood loss in adult spinal surgery. Eur Spine J 2004;13:S3-S5
- Lewis KM, Atlee HD, Mannone AJ, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg 2013;26:141-8
- Price JS, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ 2015;18:777-86
- Ramirez M, Deutsch H, Khanna N, et al. Floseal only versus in combination in spine surgery: a comaparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hospital Practice 2017; 23 Jul 2018;1–8
- Floseal VH. S/D Instructions for Use. Deerfield, IL: Baxter Healthcare Corporation, 2005
- Coenye KE, Bourgain C, Keibl C, et al. A qualitative morphological comparison of two haemostatic agents in a porcine liver trauma model. Surgical Science 2013;4:359
- Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88:1520-6
- Gelfoam. Instructions for Use. New York, NY: Pfizer Corporation, 2013
- Renkens KL Jr., Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 2001;26:1645-50
- Chapman WC, Singla N, Genyk Y, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg 2007;205:256-65
- Mozet C, Prettin C, Dietze M, et al. Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 2012;269:2247-54
- Makhija D, Rock M, Ikeme S, et al. Cost–consequence analysis of two different active flowable hemostatic matrices in spine surgery patients. J Med Econ 2017;20:606-13
- Tackett SM, Sugarman R, Kreuwel HT, et al. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ 2014;17:670-6
- Makhija D, Rock M, Xiong Y, et al. Cost–consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures. J Med Econ 2017;20:565-73
- Healthcare Cost and Utilization Project (HCUP). HCUP National Inpatient Sample (NIS). Rockville (MD): Agency for Healthcare Research and Quality, 2012
- Baxter Wholesale Acquisition Cost (WAC). Hayward (CA): Baxter Healthcare Corporation, 2017
- IMS. National Sales Perspective. Danbury (CT): IMS Health Inc., 2017
- Chatterjee A, Payette MJ, Demas CP, et al. Opportunity cost: a systematic application to surgery. Surgery 2009;146:18-22
- University Hospitals Cleveland Medical Center. Room and board per day charge, adult semi-private standard 2018. Available at: http://www.uhhospitals.org/rainbow/patients-and-visitors/billing-insurance-and-medical-records/patient-pricing-information [Last accessed 4 January 2018]
- Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135
- Fuller RL, McCullough EC, Bao MZ, et al. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financ Rev 2009;30:17-32